Report says COVID-19 patients respond to Gilead's remdesivir, shares surge
Gilead Sciences Inc's shares surged 16% in after hours trading on Thursday following a media report detailing encouraging partial data from trials of the US company's experimental drug remdesivir in severe COVID-19 patients.
from bdnews24.com - Home https://ift.tt/34IQAQl
from bdnews24.com - Home https://ift.tt/34IQAQl
No comments